Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 16/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 15/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.36 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26961745 | 0.93 | PDE4B (0.40) | MCHR1KCNH2TLR8TLR7PDE4B | |
| SCHEMBL26961578 | 0.88 | MCHR1 (0.41) | MCHR1KCNH2PDE4B | |
| SCHEMBL26961790 | 0.88 | KCNH2 (0.34) | MCHR1KCNH2TLR8TLR7 | |
| SCHEMBL26961891 | 0.82 | KCNH2 (0.34) | MCHR1KCNH2PDE4BSMN1; SMN2 | |
| SCHEMBL26962000 | 0.81 | PDE4B (0.40) | MCHR1KCNH2PDE4BSMN1; SMN2 | |
| SCHEMBL26961538 | 0.80 | MAPT (0.36) | MCHR1KCNH2 | |
| SCHEMBL26961949 | 0.77 | GRM2 (0.32) | — | |
| SCHEMBL26961664 | 0.77 | GCGR (0.35) | — | |
| SCHEMBL26961764 | 0.77 | NPY1R (0.33) | MCHR1KCNH2 | |
| SCHEMBL26961619 | 0.77 | NPY1R (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291558-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2023-12-20 | — | — | EP | disclosed |